Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Clinical Trials: Bipolar Disorder
A listing of clinical trials currently looking for volunteers to enroll in Bipolar Disorder studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Forest Investigative Site 021
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Dothan : Call for Information (Investigational Site 0018)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Dothan : Call for Information (Investigational Site 0018)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Arizona
Scottsdale : Call for Information (Investigational Site 0006)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Scottsdale : Call for Information (Investigational Site 0006)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Arkansas
Little Rock : Call for Information (Investigational Site 0011)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Little Rock : Call for Information (Investigational Site 0086)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Little Rock : Call for Information (Investigational Site 0011)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Little Rock : Call for Information (Investigational Site 0086)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
California
Cerritos : Comprehensive Clinical Development - Cerritos, CA
Bipolar Depression
Cerritos : Comprehensive Clinical Development - Cerritos, CA
Bipolar Disorder ITN# 11928CA
Imperial : Sun Valley Research Center
Do you suffer from Bipolar Depression?
Sherman Oaks : Schuster Medical Research Institute
Do You suffer from Bipolar Depression?
View More »
Anaheim : Call for Information (Investigational Site 0013)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Anaheim : Call for Information (Investigational Site 0013)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Beverly Hills : Forest Investigative Site 030
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Cerritos : Forest Investigative Site 018
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Colton : Call for Information (Investigational Site 0085)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Colton : Call for Information (Investigational Site 0085)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Costa Mesa : ATP Clinical Research, Inc.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Costa Mesa : Call for Information (Investigational Site 0107)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Costa Mesa : Call for Information (Investigational Site 0107)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Costa Mesa : Forest Investigative Site 028
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Downey : Diligent Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Escondido : Synergy Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Escondido : Call for Information (Investigational Site 0061)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Escondido : Call for Information (Investigational Site 0061)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Garden Grove :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Glendale :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
Los Angeles :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
Murrieta : Call for Information (Investigational Site 0083)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Murrieta : Call for Information (Investigational Site 0083)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
National City :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Oceanside : Forest Investigative Site 015
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Orange :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Paramount :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Pico Rivera :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
San Diego : Call for Information (Investigational Site 0035)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
San Diego : Call for Information (Investigational Site 0043)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
San Diego :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
San Diego : Call for Information (Investigational Site 0043)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
San Diego : Call for Information (Investigational Site 0035)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
San Diego :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
San Diego : Forest Investigative Site 022
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
San Francisco : Call for Information (Investigational Site 0021)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
San Francisco : Call for Information (Investigational Site 0021)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Santa Ana : Call for Information (Investigational Site 0096)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Santa Ana :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Santa Ana : Call for Information (Investigational Site 0096)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Stanford : Call for Information (Investigational Site 0009)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Stanford : Call for Information (Investigational Site 0009)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Temecula : Forest Investigative Site 011
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Torrance :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Wildomar :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Colorado
Colorado Springs : Call for Information (Investigational Site 0067)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Colorado Springs : Call for Information (Investigational Site 0067)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Connecticut
Hartford : Call for Information (Investigational Site 0033)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Hartford : Call for Information (Investigational Site 0033)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Norwalk :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
District of Columbia
Washington : Comprehensive Clinical Development - Washington, DC
Biopolar Disorder ITN# 11928DC
View More »
Washington : Call for Information (Investigational Site 0060)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Washington : Call for Information (Investigational Site 0065)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Washington :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Washington : Call for Information (Investigational Site 0060)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Washington : Call for Information (Investigational Site 0065)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Florida
Bradenton : Florida Clinical Research Center - Bradenton/Sarasota
Feeling Down or Sad?
Miami : Pharmax Research Clinic, Inc.
Bipolar Disorder Type I
Miami : Pharmax Research Clinic, Inc.
Males and Females between 18 and 90 years of age, suffering of Bipolar Disorder Type I for at least two years.
View More »
Fort Myers :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Gainesville : Call for Information (Investigational Site 0048)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Gainesville : Call for Information (Investigational Site 0048)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Hollywood : Segal Institute for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Jacksonville :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Jacksonville : Forest Investigative Site 012
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Jacksonville Beach : Call for Information (Investigational Site 0025)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Jacksonville Beach : Call for Information (Investigational Site 0025)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Juno Beach : Advanced Mental Health Care Inc. - Juno Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Lauderhill : Call for Information (Investigational Site 0051)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Lauderhill : Call for Information (Investigational Site 0051)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Orange City : Call for Information (Investigational Site 0056)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Orange City :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Orange City : Call for Information (Investigational Site 0056)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Orlando : Call for Information (Investigational Site 0026)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Orlando : Call for Information (Investigational Site 0026)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Orlando : Forest Investigative Site 035
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Tampa : Call for Information (Investigational Site 0005)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Tampa :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Tampa : Call for Information (Investigational Site 0005)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Winter Park : Forest Investigative Site 013
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Georgia
Atlanta : Comprehensive Clinical Development - Atlanta, GA
Do you suffer from Bipolar Depression? ITN# 11312
Atlanta : Comprehensive Clinical Development - Atlanta, GA
Do you suffer from Bipolar Depression? ITN#09343
View More »
Atlanta : Call for Information (Investigational Site 0045)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Atlanta : Call for Information (Investigational Site 0045)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Atlanta : Forest Investigative Site 005
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Atlanta : Forest Investigative Site 038
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Smyrna : Call for Information (Investigational Site 0003)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Smyrna :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Smyrna : Call for Information (Investigational Site 0003)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Idaho
Coeur d'Alene : Call for Information (Investigational Site 0090)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Coeur d'Alene : Call for Information (Investigational Site 0090)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Preventing the Recurrence of Depression in Bipolar Disorder
Hoffman Estates : Alexian Brothers Hospital Network
A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with acute mania associated with Bipolar I Disorder
Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.
Depression in Bipolar Disorder - Relapse Prevention
View More »
Chicago : NPI, University of Illinois at Chicago
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
Chicago : Forest Investigative Site 029
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Libertyville : Call for Information (Investigational Site 0017)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Libertyville : Call for Information (Investigational Site 0017)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Naperville : Call for Information (Investigational Site 0004)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Naperville : Call for Information (Investigational Site 0004)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Naperville :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
Skokie :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Indiana
Indianapolis : Forest Investigative Site 024
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Terre Haute : Call for Information (Investigational Site 0019)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Terre Haute : Call for Information (Investigational Site 0019)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Kansas
Prairie Village : Forest Investigative Site 031
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Wichita : Call for Information (Investigational Site 0049)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Wichita : Call for Information (Investigational Site 0049)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Louisiana
Lake Charles : Call for Information (Investigational Site 0058)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Lake Charles : Call for Information (Investigational Site 0058)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Shreveport : Call for Information (Investigational Site 0062)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Shreveport :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Shreveport : Call for Information (Investigational Site 0062)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Maryland
Baltimore : Johns Hopkins University
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Towson : Forest Investigative Site 001
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Massachusetts
Haverhill : ActivMed Practices & Research, Inc.
Are you or a loved one suffering from symptoms of Bipolar Disorder?
Haverhill : ActivMed Practices & Research, Inc.
Are you or a loved one suffering from symptoms of Bipolar Disorder?
View More »
Cambridge : Call for Information (Investigational Site 0101)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Cambridge : Call for Information (Investigational Site 0101)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Cambridge : Cambridge Health Alliance
Ropinirole in the Treatment of Bipolar Depression
Mississippi
Flowood : Call for Information (Investigational Site 0080)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Flowood :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Flowood : Call for Information (Investigational Site 0080)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Missouri
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Bipolar Disorder Research Study Seeks Volunteers.
View More »
Creve Coeur : Call for Information (Investigational Site 0081)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Creve Coeur : Call for Information (Investigational Site 0081)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Creve Coeur : Forest Investigative Site 026
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
St Louis :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
St. Louis : Scientella LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Nebraska
Lincoln : Call for Information (Investigational Site 0071)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Lincoln : Call for Information (Investigational Site 0071)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Nevada
Las Vegas : Forest Investigative Site 037
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
New Jersey
Cherry Hill :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Cherry Hill : Forest Investigative Site 023
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Marlton : CRI Lifetree
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Willingboro : Forest Investigative Site 014
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
New Mexico
Albuquerque : Forest Investigative Site 006
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
New York
Bronx : Biomedical Research Alliance of New York Updated
Bipolar Disorder
Bronx : Biomedical Research Alliance of New York
Bipolar Disorder
Fresh Meadows : Comprehensive Clinical Development - Queens, NY
olar Disorder ITN# 11928NY
New York : Medical & Behavioral Health Research, PC
Bipolar Depression
New York : Medical & Behavioral Health Research, PC
Bipolar Depression Research Study
View More »
Amherst : Call for Information (Investigational Site 0007)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Amherst : Call for Information (Investigational Site 0007)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Brooklyn : Forest Investigative Site 003
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Cedarhurst :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Fresh Meadows :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Glen Oaks : The Zucker Hillside Hospital
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Glen Oaks : Call for Information (Investigational Site 0079)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Glen Oaks : Call for Information (Investigational Site 0079)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
New York :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
New York : Mount Sinai Hospital
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New York :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
New York : Forest Investigative Site 025
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Rochester : Call for Information (Investigational Site 0002)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Rochester :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Rochester : Call for Information (Investigational Site 0002)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Staten Island : Call for Information (Investigational Site 0104)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Staten Island : Call for Information (Investigational Site 0104)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Stonybrook : Call for Information (Investigational Site 0008)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Stonybrook : Call for Information (Investigational Site 0008)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
North Carolina
Wilmington : PMG Research of Wilmington
Have you been diagnosed with Bipolar Disorder?
View More »
Durham : Forest Investigative Site 004
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Raleigh :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Ohio
Avon Lake : Call for Information (Investigational Site 0001)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Avon Lake : Call for Information (Investigational Site 0001)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Canton : Call for Information (Investigational Site 0032)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Canton : Call for Information (Investigational Site 0032)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Canton : Forest Investigative Site 036
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
View More »
Cincinnati : Call for Information (Investigational Site 0010)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Cincinnati : Call for Information (Investigational Site 0010)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Cleveland : Call for Information (Investigational Site 0015)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Cleveland : Call for Information (Investigational Site 0015)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Cleveland : University Hospitals Case Medical Center
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Dayton : Midwest Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Dayton :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Dayton : Forest Investigative Site 008
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Garfield Heights : Call for Information (Investigational Site 0044)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Garfield Heights : Call for Information (Investigational Site 0044)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Mason : Lindner Center of HOPE
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Mason : Lindner Center of HOP
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Oklahoma
Oklahoma City : Call for Information (Investigational Site 0050)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Oklahoma City : Call for Information (Investigational Site 0070)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Oklahoma City : Call for Information (Investigational Site 0023)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Oklahoma City : Call for Information (Investigational Site 0078)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Oklahoma City : Call for Information (Investigational Site 0078)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
View More »
Oklahoma City : Call for Information (Investigational Site 0023)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Oklahoma City : Call for Information (Investigational Site 0050)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Oklahoma City : Call for Information (Investigational Site 0070)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Tulsa : Call for Information (Investigational Site 0100)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Tulsa : Call for Information (Investigational Site 0100)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Oregon
Portland : Summit Research Network (Oregon), Inc.
Are you struggling with the mood swings of bipolar disorder?
Portland : Summit Research Network (Oregon), Inc.
Bipolar Clinical Research Study
View More »
Portland :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Pennsylvania
Media : Suburban Research Associates
Have you been diagnosed with Bipolar Disorder and are taking mood stabilizer medication?
View More »
Allentown : Lehigh Center for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Allentown :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Allentown : Forest Investigative Site 009
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Dubois : Dubois Regional Medical Center
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Media : Forest Investigative Site 010
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Philadelphia : Call for Information (Investigational Site 0031)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Philadelphia : Call for Information (Investigational Site 0031)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Pittsburgh : Western Psychiatric Institute and Clinic
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Rhode Island
Lincoln : Lincoln Research - Rhode Island
Suffering from bipolar depression and are depressed and on medication?
South Carolina
Charleston : Call for Information (Investigational Site 0012)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Charleston : Call for Information (Investigational Site 0091)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Charleston : Call for Information (Investigational Site 0012)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Charleston : Call for Information (Investigational Site 0091)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Charleston : Medical University of South Carolina
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Tennessee
Memphis : Call for Information (Investigational Site 0054)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Memphis : Call for Information (Investigational Site 0054)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Memphis : Forest Investigative Site 019
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Texas
Dallas : Research Across America
Adolescent Bipolar Type I Research Study
Dallas : Research Across America
Bipolar Type I Research Study
Houston : Bayou City Research Corporation
Bipolar Depression study with 6-month open-label therapy
Houston : Bayou City Research Corporation
Do your moods go up and down like a rollercoster?
Lake Jackson : R/D Clinical Research, Inc.
A Randomized, Double-Bllind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects with BiPolar I Disorder
Lake Jackson : R/D Clinical Research, Inc.
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated with Bipolar I Disorder
View More »
Ausitn : Senior Adults Specialty Research
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Austin : Call for Information (Investigational Site 0072)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Austin : Call for Information (Investigational Site 0072)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Dallas : Call for Information (Investigational Site 0037)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Dallas :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Dallas : Call for Information (Investigational Site 0037)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Dallas : UT Southwestern Medical Center at Dallas
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Dallas : Forest Investigative Site 007
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
DeSoto : Call for Information (Investigational Site 0053)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
DeSoto : Call for Information (Investigational Site 0053)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Houston : Claghorn-Lesem Research Clinic
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston : Call for Information (Investigational Site 0016)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Houston : Call for Information (Investigational Site 0097)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Houston :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Houston : Call for Information (Investigational Site 0016)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Houston : Call for Information (Investigational Site 0097)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Houston : Forest Investigative Site 016
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Houston : Forest Investigative Site 027
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Lake Jackson : Call for Information (Investigational Site 0024)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
San Antonio : Univ of Texas Helath Science Center at San Antonio
12- Week Open Label Treatment of Refractory Bipolar Depression
San Antonio : Forest Investigative Site 020
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
San Antonio : Forest Investigative Site 034
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
The Woodlands : Call for Information (Investigational Site 0105)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
The Woodlands : Call for Information (Investigational Site 0105)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Wharton : Call for Information (Investigational Site 0041)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Wharton : Call for Information (Investigational Site 0041)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Utah
Salt Lake City : CRI Lifetree
To assess the efficacy of ELND005 compared to placebo as adjunctive maintenance therapy in patients with BPD I, as evidenced by a delay in the time to recurrence of any type of mood episode in the randomized phase of the study
View More »
Salt Lake City : Lifetree Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Salt Lake City : Call for Information (Investigational Site 0063)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Salt Lake City : Call for Information (Investigational Site 0063)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Virginia
Charlottesville : Call for Information (Investigational Site 0093)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Charlottesville : Call for Information (Investigational Site 0093)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Washington
Seattle : Summit Research Network (Seattle) LLC
Are you dealing with Bipolar Disorder?
Seattle : Summit Research Network (Seattle) LLC
Bipolar Disorder Research Study
View More »
Bothell : Call for Information (Investigational Site 0039)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Bothell : Call for Information (Investigational Site 0039)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Bothell :
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
Kirkland : Call for Information (Investigational Site 0029)
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Kirkland :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Kirkland : Call for Information (Investigational Site 0029)
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM3)
Richland : Scientella, LLC.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Seattle :
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder in Adult Patients
Seattle : Forest Investigative Site 032
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Tacoma and Seattle : VA Puget Sound Health Care System
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Bulgaria
Pleven : Forest Investigative Site 302
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Plovdiv : Forest Investigative Site 301
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Sofia : Forest Investigative Site 306
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Canada
Chatham : Forest Investigative Site 101
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services
Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
Kelowna : Okanagan Clinical Trials
Lurasidone Extended Use Study
Kelowna : Forest Investigative Site 102
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Medicine Hat : Forest Investigative Site 104
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
View More »
Montréal : Douglas Mental Health University Institute
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
Penticton : Forest Investigative Site 103
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Toronto : University Health Network - Toronto General Division
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Toronto : University Health Network - Toronto Western Division
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Toronto : Sunnybrook Health Sciences Centre
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
Vancouver : BC Mental Health & Addictions Research Institute
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
Vancouver : Institute of Mental Health, University of British Columbia
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
China
Baoding : GSK Investigational Site
Lamotrigine Phase III Study in Bipolar I Disorder
Beijing : GSK Investigational Site
Lamotrigine Phase III Study in Bipolar I Disorder
Beijing : Institute of mental health, Peking University
The Third Survey of Prescription Pattern of Psychotropic Drugs in China
Kunming : GSK Investigational Site
Lamotrigine Phase III Study in Bipolar I Disorder
Shanghai : GSK Investigational Site
Lamotrigine Phase III Study in Bipolar I Disorder
Colombia
Czech Republic
Denmark
Copenhagen : Psychiatric Centre Copenhagen, Rigshospitalet, Denmark
The Effects of Cognitive Remediation on Remitted Bipolar Disorder - a Proof of Concept Study
France
Orvault : Zans Ritter, Marcel
Lurasidone Extended Use Study
India
Israel
Hod Hasharon : shalvataMHC
Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression
Japan
Chubu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Chugoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Hokkaido :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Hokkaido :
Long-term Study of FK949E in Elderly Bipolar Disorder Patients
Kansai :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
View More »
Kanto :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Kyushu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Shikoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Touhoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Lithuania
Poland
Romania
Russian Federation
Nizhniy Novgorod : Forest Investigative Site 603
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
St. Petersburg : Forest Investigative Site 604
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
St. Petersburg : Forest Investigative Site 602
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
St. Petersburg : Forest Investigative Site 606
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
St. Petersburg : Forest Investigative Site 608
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Slovakia
South Africa
Pretoria : Dey Clinic
Lurasidone Extended Use Study
Tygervalley : Cape Trial Centre
Lurasidone Extended Use Study
Switzerland
Basel : University Hospital Basel
General Practice Research Database Seroquel XR Safety Study
Taiwan
Tainan : Ru-Band Lu
Add-on Dextromethorphan in Bipolar Disorders
Ukraine
Dnipropetrovsk : Dnipropetrovsk Regional Clinical Hospital named Mechnikov
Lurasidone Extended Use Study
Donetsk : Regional Clinical Psychiatric Hospital, Dept #11
Lurasidone Extended Use Study
Kharkiv : Forest Investigative Site 703
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Kharkov : Forest Investigative Site 704
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Kherson : Kherson Regional Psychiatric Hospital
Lurasidone Extended Use Study
View More »
Kyiv : Forest Investigative Site 701
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Simferopol : Crimean republican Clinical Psychiatric Hospital
Lurasidone Extended Use Study
Simferopol : Forest Investigative Site 706
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Vinnitsa : Forest Investigative Site 705
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Vinnitsia : Reg. Psych. Hosp.n.a.O.Yuschenko, Dept #21
Lurasidone Extended Use Study
